Head and Neck Cancer Therapeutics Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027, Segmented By Type (Diagnostic Methods, Treatment Type), By Diagnostic Methods (Biopsy, Imaging, Endoscopy, Others), By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By Disease Indication (Lip and Oral Cavity Cancer, Laryngeal Cancer, Orop
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationHead and Neck Cancer Therapeutics Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027, Segmented By Type (Diagnostic Methods, Treatment Type), By Diagnostic Methods (Biopsy, Imaging, Endoscopy, Others), By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By Disease Indication (Lip and Oral Cavity Cancer, Laryngeal Cancer, Orop
Global Head and Neck Cancer Therapeutics Market stood at USD2024.33 million in 2021 and is expected to grow at an impressive rate of 7.22% during the forecast period. This can be ascribed to the growing popularity of precision medicine and the need for new therapies for the treatment of different types of head and neck cancers. Furthermore, growing consumption of tobacco and alcohol is further contributing to the increasing incidences of head and neck cancers. According to World Health Organization, Tobacco kills nearly half of its users, accounting for around 8 million deaths every year. Out of which, 7 million deaths are caused due to direct tobacco use, while the remaining is caused due to the exposure of nonsmokers to passive smoking.
Increasing Number of Clinical Trials
The increasing research & development activities related to the development of different types of therapies related to head and neck cancer has significantly augmented the number of clinical trials related to the same. There are around 2957 clinical trials launched on head and neck cancer till date. In 2021, around 52 clinical trials were launched globally related to head and neck cancer. This count is expected to increase in the coming years, thereby supporting the market growth in the coming years.
Growing Adoption of New Treatments
Development of immunotherapies, CAR-T cell therapies, among others for the treatment of different types of cancer is expected to drive the growth of head and neck cancer therapeutics market. Several clinical trials related to immunotherapies and targeted therapies are going on. In the forecast period, several advanced therapies can be expected to treat head and neck cancer.
Increasing Number of Players
Many healthcare players are either developing drugs or therapies for the treatment of head and neck cancer or collaborating with other companies who have developed the therapy or drug earlier. Some healthcare majors are simply acquiring the smaller ones and expanding their portfolio of head and neck cancer therapeutic solutions. This, in turn, is leading to a lot of investment in the head and neck cancer therapeutics industry. For instance, in January 2021, AbbVie, Inc. developed SkinMedica Neck Correct Cream, which focuses on the biology of the skin on the neck and decollete area.
DOWNLOAD FREE SAMPLE REPORT
Market Segmentation
North America dominates the overall Head and Neck Cancer Therapeutics Market with United States having the biggest market. The United States Head and Neck Cancer Therapeutics Market stood at USD562.21 million in 2021.
Major companies in the market are Eli Lilly and Company, Bristol Myers Squibb Company, Sanofi S.A., Merck & Co., Inc., Pfizer Inc, AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, AstraZeneca Plc., Astellas Pharma Inc., AB Science SA, Boston Biomedical, Inc., among others. Major players operating in the market are following strategies such as mergers and acquisitions, new therapy or drug launches, and others to stay competitive and have an edge over other players in the market.
| Attribute | Details |
| Market Size Value in 2021 | USD2024.33 million |
| Revenue Forecast in 2027 | USD3126.26 million |
| United States Market Size Value in 2021 | USD562.21 million |
| Growth Rate | 7.22% |
| Base Year | 2021 |
| Historical Years | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million and CAGR for 2017-2021 and 2022-2027 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | · Type o Diagnostic Methods o Treatment Type S Disease Indication S Route of Administration S Therapeutic Class · End User |
| Regional Scope | North America; Asia Pacific; Europe, South America; Middle East & Africa |
| Country Scope | United States; Canada; Mexico; Germany; France; United Kingdom; Italy; Spain; China; India; Japan; Australia; South Korea; Singapore; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
| Key Companies Profiled | Eli Lilly and Company, Bristol Myers Squibb Company, Sanofi S.A., Merck & Co., Inc., Pfizer Inc, AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, AstraZeneca Plc., Astellas Pharma Inc., AB Science SA, Boston Biomedical, Inc. |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy